FY24 consensus $4.25. The company updates full-year 2024 guidance as follows: Organic revenue growth trending toward the lower end of the range of 1% to 2% year-over-year, given the continued China market softness; Adjusted EBIT margin in the range of 15.8% to 16.0%, reflecting an expansion of 70 to 90 basis points versus 2023; Adjusted EBIT margin of 15.1%; this compares to prior guidance of 15.7% to 16.0%; Adjusted effective tax rate trending toward the lower end of the 23% to 25% range, given additional tax incentives recognized in third quarter 2024; Free cash flow of approximately $1.8B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Notable companies reporting before tomorrow’s open
- GE HealthCare announces CareIntellect for Oncology application
- General Electric (NYSE:GE) Earnings Preview: Here’s What to Expect
- GE HealthCare says major academic medical center adopts Hospital Pulse Tile
- GE HealthCare completes manganese-based MRI clinical development program